封面
市场调查报告书
商品编码
1421658

尿路结石管理设备市场、份额、规模、趋势、行业分析报告:按治疗类型、最终用途、地区、细分市场、预测,2023-2032 年

Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy); By End-use; By Region, And Segment Forecasts, 2023 - 2032

出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究,到 2032 年,全球尿路结石治疗设备市场规模预计将达到 35.1 亿美元。 该研究报告提供了对当前市场动态的详细洞察,并对未来市场成长进行了分析。

尿路结石盛行率的不断上升促使治疗方案不断进步。 根据欧洲泌尿外科协会的数据,尿路结石是一种与生活方式相关的疾病,盛行率为 10%,需要係统性的治疗方法。 尿石症是指泌尿系统中结石的形成,包括肾臟、输尿管和膀胱。 在美国、加拿大和德国,这是一个重要的医疗保健问题,大多数情况下復发率接近 50%。

尿石症可以透过改变生活方式、饮食管理和基本药物来控制,但清除引起剧烈疼痛的大结石需要多种治疗方法。 根据结石的大小、位置和解剖变化,有侵入性和非侵入性碎石技术。

最近的研究表明,无论性别如何,肾结石的盛行率已增加到大约十分之一。 此外,这些患者中有一半可能在一生中经历多次有症状的肾结石。 称为巨噬细胞的发炎细胞会影响肾结石从前驱物的发展。 最近的一项研究表明,与对照组相比,在出现有临床意义的结石的患者中,肾臟中钙沉积量的增加导致发炎巨噬细胞的活化。

体内碎石术使用内视镜识别结石并将其分解成更小的碎片。 超音波和雷射等技术用于分解结石,使较小的碎片能够通过泌尿系统。 由于其在实现无结石状态方面的高效性,体内碎石术预计将成为预测期内的首选治疗选择。 此外,经皮肾镜取石术是一种在体外或体内碎石术无效时用于去除较大结石的外科手术,通常需要住院一週。

先进手术技术(如内视镜)和微型配件(如导丝、手术刀和篮子)的引入,使得微创手术得以在短时间内有效地从泌尿系统中取出结石。改善了。

尿路结石管理设备市场报告亮点

  • 2022年,体内碎石术因其效率高且最适合男性肾结石而占据最大的市场份额。
  • 由于医院成本上升和住院时间缩短,体内碎石领域占据了最大的市场份额。
  • 在肾结石病例上升、手术介入和消费者意识的推动下,北美地区将在 2022 年占据最大的市场份额。
  • 主要市场参与者包括 Cook Medical、ConMed、DirexGroup、Dornier MedTech、KARL STORZ、Olympus、Richard Wolf 和 Siemens Healthcare。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球尿路结石治疗设备市场洞察

  • 尿路结石管理设备市场 - 产业概况
  • 尿路结石治疗设备的市场动态
    • 促进因素和机会
      • 肥胖发生率增加
      • 人口老化加剧
    • 抑制因素和挑战
      • 治疗费用高
  • PESTLE分析
  • 泌尿道结石管理设备的产业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球尿路结石治疗设备市场(依治疗类型)

  • 主要发现
  • 简介
  • 体外震波碎石术 (ESWL)
  • 内碎石术
  • 经皮肾镜取石术
  • 其他

第 6 章全球尿路结石治疗设备市场(依最终用途)

  • 主要发现
  • 简介
  • 医院和诊所
  • 日间手术中心 (ASC)

第 7 章全球尿路结石治疗设备市场(按地区)

  • 主要发现
  • 简介
    • 2019-2032 年尿路结石管理设备市场评估,地区
  • 尿路结石治疗设备市场 - 北美
    • 北美:尿路结石管理设备市场,依最终用途,2019-2032 年
    • 北美:尿路结石管理设备市场,依治疗类型,2019-2032 年
    • 尿路结石治疗设备市场 - 美国
    • 尿路结石管理设备市场 - 加拿大
  • 尿路结石治疗设备市场 - 欧洲
    • 欧洲:尿路结石管理设备市场,依最终用途,2019-2032 年
    • 欧洲:尿路结石管理设备市场,依治疗类型,2019-2032 年
    • 尿路结石管理设备市场 - 英国
    • 尿路结石治疗设备市场 - 法国
    • 尿路结石治疗设备市场 - 德国
    • 尿路结石治疗设备市场 - 义大利
    • 尿路结石治疗设备市场 - 西班牙
    • 尿路结石治疗设备市场 - 荷兰
    • 尿路结石治疗设备市场 - 俄罗斯
  • 尿路结石治疗设备市场 - 亚太地区
    • 亚太地区:尿路结石管理设备市场,依最终用途,2019-2032 年
    • 亚太地区:尿路结石管理设备市场,依治疗类型,2019-2032 年
    • 尿路结石治疗设备市场 - 中国
    • 尿路结石治疗设备市场 - 印度
    • 尿路结石治疗设备市场 - 马来西亚
    • 尿路结石治疗设备市场 - 日本
    • 尿路结石治疗设备市场 - 印度尼西亚
    • 尿路结石治疗设备市场 - 韩国
  • 尿路结石管理设备市场 - 中东和非洲
    • 中东和非洲:2019-2032 年尿路结石管理设备市场,依最终用途
    • 中东和非洲:尿路结石管理设备市场,按治疗类型,2019-2032 年
    • 尿路结石治疗设备市场 - 沙乌地阿拉伯
    • 尿路结石治疗设备市场 - 阿拉伯联合大公国
    • 尿路结石治疗设备市场 - 以色列
    • 尿路结石管理设备市场 - 南非
  • 尿路结石管理设备市场 - 拉丁美洲
    • 拉丁美洲:尿路结石管理设备市场,以最终用途,2019-2032 年
    • 拉丁美洲:尿路结石管理设备市场,依治疗类型,2019-2032 年
    • 尿路结石治疗设备市场 - 墨西哥
    • 尿路结石治疗设备市场 - 巴西
    • 尿路结石治疗设备市场 - 阿根廷

第 8 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 9 章公司简介

  • Allengens
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare
Product Code: PM3989

The global urolithiasis management devices market size is expected to reach USD 3.51 billion by 2032, according to a new study by Polaris Market Research. The report "Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising incidence of urinary stones has driven advancements in treatment options. According to the European Association of Urology, it is a prevalent lifestyle disorder with a 10% prevalence rate, necessitating a systematic treatment approach. Urolithiasis refers to the formation of stones in the urinary system, including the kidneys, ureters, & bladder. It poses a significant healthcare concern in the U.S., Canada, & Germany, with a recurrence rate of nearly 50 percent in most of the cases.

While lifestyle changes, controlled diet, and basic medication can manage urolithiasis, various treatment approaches are required for the removal of large stones causing severe pain. Depending on the stone size, location, & anatomical variations, both invasive & non-invasive stone procedures are available.

Kidney stone disease is a prevalent urologic condition among adults in the U.S. Recent studies indicate that the prevalence of kidney stones has risen to approximately 1 in 10 individuals of all genders. Additionally, half of these individuals are likely to experience multiple symptomatic kidney stones throughout their lives. Inflammatory cells called macrophages influence the development of kidney stones from precursor materials. A recent study indicated that elevated calcium deposits in the kidney led to the activation of proinflammatory macrophages in patients who developed clinically significant stones, contrasting with the control group.

Intracorporeal lithotripsy treatments involve identifying and breaking down stones into smaller fragments using endoscopy. Techniques like ultrasound or laser are employed to disintegrate stones, allowing the passage of smaller pieces through the urinary system. Due to its high effectiveness in achieving a stone-free state, intracorporeal lithotripsy is expected to be a preferred treatment option in the forecast period. Additionally, percutaneous nephrolithotomy is a surgical method used for removing larger stones when extracorporeal or intracorporeal lithotripsies are ineffective, typically requiring a week-long hospital stay.

The introduction of advanced surgical technologies like endoscopy and micro accessories such as guidewires, scalpels, and baskets has significantly improved the acceptance of minimally invasive surgeries for efficiently removing stones from the urinary system within a short timeframe.

Urolithiasis Management Devices Market Report Highlights

  • In 2022, the intra-corporeal lithotripsy segment held the largest market share, as its high efficiency rate, and most suitable for renal stones in men
  • The intra-corporeal lithotripsy segment held the largest market share, on account for rising hospitals costs, and shortened hospital stays.
  • In 2022, North America region dominated the largest market share, rising cases of renal stones, surgical interventions, and awareness among consumer
  • The key market players include Cook Medical, ConMed, DirexGroup, Dornier MedTech, KARL STORZ, Olympus, Richard Wolf, and Siemens Healthcare.

Polaris Market Research has segmented the Urolithiasis management devices market report based on treatment type, end use, and region:

Urolithiasis Management Devices, Treatment Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Intracorporeal Lithotripsy
  • Percutaneous Nephrolithotomy
  • Others

Urolithiasis Management Devices, End Use Outlook (Revenue - USD Billion, 2023 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)

Urolithiasis Management Devices, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Urolithiasis Management Devices Market Insights

  • 4.1. Urolithiasis Management Devices Market - Industry Snapshot
  • 4.2. Urolithiasis Management Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of obesity
      • 4.2.1.2. Increasing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Urolithiasis Management Devices Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Urolithiasis Management Devices Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Urolithiasis Management Devices, by Treatment Type, 2019-2032 (USD Billion)
  • 5.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 5.3.1. Global Urolithiasis Management Devices Market, by Extracorporeal Shock Wave Lithotripsy (ESWL), by Region, 2019-2032 (USD Billion)
  • 5.4. Intracorporeal Lithotripsy
    • 5.4.1. Global Urolithiasis Management Devices Market, by Intracorporeal Lithotripsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Percutaneous Nephrolithotomy
    • 5.5.1. Global Urolithiasis Management Devices Market, by Percutaneous Nephrolithotomy, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Urolithiasis Management Devices Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Urolithiasis Management Devices Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Global Urolithiasis Management Devices Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Billion)
  • 6.4. Ambulatory Surgical Centers (ASCs)
    • 6.4.1. Global Urolithiasis Management Devices Market, by Ambulatory Surgical Centers (ASCs), by Region, 2019-2032 (USD Billion)

7. Global Urolithiasis Management Devices Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Urolithiasis Management Devices Market - North America
    • 7.3.1. North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.3. Urolithiasis Management Devices Market - U.S.
      • 7.3.3.1. U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.4. Urolithiasis Management Devices Market - Canada
      • 7.3.4.1. Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.4. Urolithiasis Management Devices Market - Europe
    • 7.4.1. Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.3. Urolithiasis Management Devices Market - UK
      • 7.4.3.1. UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.4. Urolithiasis Management Devices Market - France
      • 7.4.4.1. France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.5. Urolithiasis Management Devices Market - Germany
      • 7.4.5.1. Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.6. Urolithiasis Management Devices Market - Italy
      • 7.4.6.1. Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.7. Urolithiasis Management Devices Market - Spain
      • 7.4.7.1. Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.8. Urolithiasis Management Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.9. Urolithiasis Management Devices Market - Russia
      • 7.4.9.1. Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.5. Urolithiasis Management Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.3. Urolithiasis Management Devices Market - China
      • 7.5.3.1. China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.4. Urolithiasis Management Devices Market - India
      • 7.5.4.1. India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.5. Urolithiasis Management Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.6. Urolithiasis Management Devices Market - Japan
      • 7.5.6.1. Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.7. Urolithiasis Management Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.8. Urolithiasis Management Devices Market - South Korea
      • 7.5.8.1. South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.6. Urolithiasis Management Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.3. Urolithiasis Management Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.4. Urolithiasis Management Devices Market - UAE
      • 7.6.4.1. UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.5. Urolithiasis Management Devices Market - Israel
      • 7.6.5.1. Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.6. Urolithiasis Management Devices Market - South Africa
      • 7.6.6.1. South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.7. Urolithiasis Management Devices Market - Latin America
    • 7.7.1. Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.3. Urolithiasis Management Devices Market - Mexico
      • 7.7.3.1. Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.4. Urolithiasis Management Devices Market - Brazil
      • 7.7.4.1. Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.5. Urolithiasis Management Devices Market - Argentina
      • 7.7.5.1. Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allengens
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Boston Scientific
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BD
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Cook Medical
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. ConMed
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. DirexGroup
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Dornier MedTech
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. KARL STORZ
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Potent Optotronic
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. HealthTronics
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Lumenis
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Olympus
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Richard Wolf
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Siemens Healthcare
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables

  • Table 1 Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 3 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 12 UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 28 China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Urolithiasis Management Devices Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Urolithiasis Management Devices Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment Type
  • Figure 9 Global Urolithiasis Management Devices Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 10 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Urolithiasis Management Devices Market